CBLL Stock Analysis: Buy, Sell, or Hold?
CBLL - CeriBell, Inc. Common Stock
$20.61
0.18 (0.88%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When CBLL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CBLL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CBLL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CBLL is currently trading at $20.61, which is considered oversold relative to its 30-day fair value range of $21.06 to $22.76.
Technical Outlook: Technically, CBLL is in a strong uptrend. The price is currently testing key support at $20.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $28.14 (+37.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CBLL is in a strong uptrend. The price is currently testing key support at $20.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $28.14 (+37.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$21.06 -
$22.76
Company Quality Score
52/100
(HOLD)
Options IV Signal
27th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
86.2%
Protect Your Profits
Holding CBLL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 27th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.8% below Wall St target ($28.14)
- CAUTION: Recommendation downgraded due to -7.6% 5-day decline
Fair Price Analysis
30-Day Fair Range
$21.06 -
$22.76
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.00
(9.7%)
Support & Resistance Levels
Support Level
$20.08
Resistance Level
$22.87
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-13.98
Wall Street Target
$28.14
(+37.8%)
Revenue Growth (YoY)
31.4%
Profit Margin
-63.3%
Last updated: January 30, 2026 11:56 PM ET
Data refreshes hourly during market hours. Next update: 12:56 AM
Data refreshes hourly during market hours. Next update: 12:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBLL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Raymond Woo
SELL
11112 shares
2025-10-03
David Foehr
SELL
866 shares
2025-08-27
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
Advanced CBLL Option Strategies
Professional options setups generated by AI based on today's CBLL price and gamma walls.
